Skip to main content
Clinical Trials/NCT01804283
NCT01804283UnknownNot Applicable

Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement

Central South University1 site in 1 country8 target enrollmentStarted: March 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
8
Locations
1
Primary Endpoint
Change from Baseline in Cardiac MicroRNA Expression

Study Overview

Brief Summary

  1. Cardiopulmonary bypass and cardioplegic arrest could regulate expression of microRNAs in patients undergoing double valve replacement (aortic and mitral).
  2. The modulation of myocardial microRNAs by cardiopulmonary bypass and cardioplegic arrest may be rescued by ischemic postconditioning.
  3. Downstream effectors would also be affected.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Consecutive eight patients with rheumatic heart valve disease undergoing elective double valve replacement(aortic and mitral)are considered for participation in this study.

Exclusion Criteria

  • insulin-dependent diabetes mellitus
  • pulmonary, renal, or hepatic failure
  • infective valve disease
  • valve disease with coronary artery disease
  • hypertension
  • emergency and reoperations
  • received aspirin,corticosteroids, or statin preoperatively
  • received preoperative inotropic support

Outcomes

Primary Outcomes

Change from Baseline in Cardiac MicroRNA Expression

Time Frame: before cardiopulmonary bypass and at 5 min after aortic de-clamping

Samples were harvested from all the patients, respectively, before cardiopulmonary bypass and at 5 min after aortic de-clamping. Real-time quantitative stem-loop reverse transcription polymerase chain reaction assay was performed to detect the expression of microRNAs.

Secondary Outcomes

  • Change from Baseline in Downstream Gene Expression(before cardiopulmonary bypass and at 5 min after aortic de-clamping)

Investigators

Sponsor
Central South University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Luo Wanjun

Prof.

Central South University

Study Sites (1)

Loading locations...

Similar Trials